New OTC drugs and devices 2000: a selective review.
OBJECTIVE
To create a heightened awareness of the issues confronting pharmacists in the self-care arena. To educate pharmacists about newly introduced nonprescription products, devices, and diagnostic products.


METHODS
Recently published governmental, clinical, and pharmaceutical industry literature.


RESULTS
Several developments during the previous year have important implications for patient self-care. The Food and Drug Administration recommended the withdrawal of phenylpropanolamine from the market and denied proposals to switch lovastatin, pravastatin, and omeprazole to nonprescription status. Widespread use of dietary supplements in the face of insufficient data on their safety and efficacy continued to be a problem in 2000, although there were several encouraging developments. In 2000, new over-the-counter products were introduced for, among other purposes, treating acid-peptic disorders, musculoskeletal injuries, dermatologic disorders, and minor wounds. Numerous nonprescription products, including sophisticated home diagnostic products and accessories, continue to become available on the U.S. market. It is important that the pharmacist become as knowledgeable as possible about these products so he or she can educate patients about their appropriate use.


CONCLUSIONS
Patients will continue to place an increasing emphasis on self-care. To assist them, pharmacists must remain up to date on trends and have a balanced understanding of new products. The new nonprescription medications and diagnostic products discussed in this review article represent valuable additions to the growing array of self-care products.
Newton
G D
GD
School of Pharmacy and Pharmacal Sciences, Purdue University, West Lafayette, Ind 47907-1335, USA.
Pray
W S
WS
Popovich
N G
NG
D004864:Equipment and Supplies; D006801:Humans; D004366:Nonprescription Drugs; D012656:Self-Help Devices; D014481:United States; D014486:United States Food and Drug Administration
D004366:Nonprescription Drugs